1. Home
  2. REPL vs HAFC Comparison

REPL vs HAFC Comparison

Compare REPL & HAFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$5.34

Market Cap

692.8M

Sector

Health Care

ML Signal

HOLD

Logo Hanmi Financial Corporation

HAFC

Hanmi Financial Corporation

HOLD

Current Price

$29.13

Market Cap

821.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
REPL
HAFC
Founded
2015
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
692.8M
821.2M
IPO Year
2018
2000

Fundamental Metrics

Financial Performance
Metric
REPL
HAFC
Price
$5.34
$29.13
Analyst Decision
Hold
Hold
Analyst Count
9
3
Target Price
$5.67
$32.17
AVG Volume (30 Days)
8.1M
230.1K
Earning Date
05-21-2026
04-21-2026
Dividend Yield
N/A
3.75%
EPS Growth
5.25
22.44
EPS
N/A
0.75
Revenue
N/A
$270,165,000.00
Revenue This Year
N/A
$18.65
Revenue Next Year
N/A
$7.28
P/E Ratio
N/A
$39.20
Revenue Growth
N/A
15.28
52 Week Low
$1.50
$21.84
52 Week High
$13.24
$31.33

Technical Indicators

Market Signals
Indicator
REPL
HAFC
Relative Strength Index (RSI) 62.53 50.57
Support Level $4.39 $26.13
Resistance Level $5.84 $29.46
Average True Range (ATR) 0.53 0.69
MACD 0.43 -0.19
Stochastic Oscillator 96.61 9.30

Price Performance

Historical Comparison
REPL
HAFC

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

About HAFC Hanmi Financial Corporation

Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.

Share on Social Networks: